| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0B | $4.2B | $4.2B | $3.9B | $3.5B | $3.4B | $3.3B | — |
| Cost of Revenue | $1.6B | $1.7B | $1.7B | $1.5B | $1.4B | $1.2B | $1.2B | — |
| Gross Profit | $2.3B | $2.5B | $2.5B | $2.4B | $2.1B | $2.1B | $2.2B | $2.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.7B | $0.8B | $0.7B | $0.7B | $0.7B | $0.6B | $0.6B | $0.8B |
| Operating Income | $1.1B | $1.4B | $1.1B | $1.2B | $1.2B | $1.1B | $1.1B | $1.0B |
| Net Income | $0.9B | $1.0B | $0.8B | $0.8B | $0.9B | $0.8B | $0.8B | $0.7B |
| EPS (Basic) | $1.84 | $2.15 | $1.63 | $1.75 | $1.89 | $1.73 | $1.74 | $1.49 |
| EPS (Diluted) | $1.84 | $2.14 | $1.63 | $1.74 | $1.88 | $1.72 | $1.73 | $1.48 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.1B | $8.2B | $7.8B | $6.4B | $6.5B | $5.8B | $5.1B | $5.0B |
| Current Assets | $4.2B | $4.0B | $3.8B | $3.8B | $3.9B | $3.3B | $2.7B | $2.6B |
| Cash & Equivalents | $0.4B | $0.4B | $0.4B | $0.9B | $1.1B | $0.7B | $0.3B | $0.2B |
| Total Liabilities | $4.1B | $4.6B | $4.5B | $3.6B | $3.9B | $3.8B | $3.5B | $3.7B |
| Current Liabilities | $1.1B | $1.6B | $1.1B | $1.0B | $0.9B | $0.9B | $0.7B | $0.8B |
| Stockholders' Equity | $4.0B | $3.5B | $3.3B | $2.7B | $2.7B | $2.0B | $1.6B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.6B | $0.9B | $0.8B | $0.7B | $0.8B | $0.6B |
| Investing Cash Flow | $0.2B | $0.0B | $-1.4B | $-0.1B | $0.1B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.8B | $-0.6B | $0.2B | $-1.0B | $-0.5B | $-0.2B | $-0.6B | $-0.5B |